Skip to Main Content
Back to News

Lobbying Update: $400,000 of ILLUMINA INC. lobbying was just disclosed

None

$400,000 of ILLUMINA INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization General discussions related to Cures 2.0 H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security"

You can find more data on corporate lobbying on Quiver Quantitative.

ILMN Congressional Stock Trading

Members of Congress have traded $ILMN stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $ILMN stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ILMN Hedge Fund Activity

We have seen 398 institutional investors add shares of ILMN stock to their portfolio, and 376 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles